{
    "organizations": [],
    "uuid": "570169727939ec63f3d8b5f83c72d2ada18fb030",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shire-plc-says-us-fda-has-accepted/brief-shire-plc-says-u-s-fda-has-accepted-biologics-license-application-for-calaspargase-pegol-idUSASB0C7XF",
    "ord_in_thread": 0,
    "title": "BRIEF-Shire Plc Says ‍U.S. FDA Has Accepted Biologics License Application For Calaspargase Pegol​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 28, 2018 / 7:21 AM / Updated 39 minutes ago BRIEF-Shire Plc Says ‍U.S. FDA Has Accepted Biologics License Application For Calaspargase Pegol​ Reuters Staff 1 Min Read Feb 28 (Reuters) - Shire Plc: * U.S. FDA ACCEPTS SHIRE‘S BIOLOGICS LICENSE APPLICATION FOR CALASPARGASE PEGOL (CAL-PEG) FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) * ‍U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS ACCEPTED BIOLOGICS LICENSE APPLICATION (BLA) FOR CALASPARGASE PEGOL​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-28T15:21:00.000+02:00",
    "crawled": "2018-02-28T10:02:03.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "updated",
        "minute",
        "ago",
        "plc",
        "say",
        "fda",
        "accepted",
        "biologics",
        "license",
        "application",
        "calaspargase",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "shire",
        "plc",
        "fda",
        "accepts",
        "shire",
        "biologics",
        "license",
        "application",
        "calaspargase",
        "pegol",
        "acute",
        "lymphoblastic",
        "leukemia",
        "food",
        "drug",
        "administration",
        "fda",
        "accepted",
        "biologics",
        "license",
        "application",
        "bla",
        "calaspargase",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}